查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1495544

依替唑侖市場：依形式、應用分類 - 全球預測 2024-2030

Etizolam Market by Form (Powders, Solutions, Tablet), Applications (Anxiety, Insomnia, Panic Disorders) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年依替唑侖市場規模為6,815萬美元，2024年達7,133萬美元，預計2030年將達9,507萬美元，複合年成長率為4.86%。

依替唑侖是噻吩並二氮雜卓類藥物中的一種化合物，其結構和功能與苯二氮平類藥物相似。它主要用於鎮靜和抗焦慮作用。它的作用是增強大腦中一種名為 GABA 的神經傳導物質的作用，這種神經傳導物質在調節神經系統活動方面發揮作用，並對身體有鎮靜作用。依替唑侖可有效治療焦慮和失眠，但它也存在潛在的風險和副作用，包括依賴性。越來越多的人患有焦慮和睡眠障礙，這增加了對依替唑侖等有效治療方法的需求。然而，有關依替唑侖核准的嚴格規定給製造商帶來了重大挑戰。此外，最近的技術進步使得醫學領域的研究變得更加有效和有針對性。對於依替唑侖市場，增加研發投資可能會導致開發出更安全、更有效、副作用更少的製劑。這可能會擴大依替唑侖的治療用途，並將其定位為需要苯二氮平樣作用的治療的首選。

主要市場統計
基準年[2023] 6815萬美元
預測年份 [2024] 7133萬美元
預測年份 [2030] 9507萬美元
複合年成長率（%） 4.86%

區域洞察

在美洲，依替唑侖未經美國食品藥物管理局(FDA)核准。由於擔心濫用和成癮，它在美國的幾個州是非法的。同時，加拿大認知到濫用依替唑侖的可能性，並致力於對進口和分銷進行嚴格的監管和監控。美洲市場受到監管政策的強烈影響，進而對消費行為產生重大影響。在受監管的領域，人們明顯傾向於購買合法且同樣有效的替代品。美國是醫藥創新中心，目前正在進行多項關於更安全的依替唑侖替代品的研究，重點是降低依賴風險。專利通常圍繞著配方改進或相關物質的新治療用途。依替唑侖的法律地位在歐盟國家之間有所不同，但與亞洲相比，其使用普遍受到控制，對處方和分銷有嚴格的規定。歐盟國家廣泛關注心理健康，為研究更安全、更有效的依替唑侖替代品鋪平了道路。此外，中東有嚴格的毒品法，減少了此類化合物的供應。相較之下，非洲的監管控制各不相同，很大程度上受到國家政策的影響，進而影響可用性和消費行為。此外，亞洲、中國、日本和印度對於依替唑侖市場極為重要，這主要是因為它們人口眾多且監管狀況各異。在日本，依替唑侖經常用於醫療機構，但受到嚴格控制。與日本不同，中國和印度對依替唑侖的監管較不嚴格，因此相對較容易取得，並且具有不同的使用和購買模式。最近在印度和中國的投資重點是擴大藥品生產能力，包括生產各種抗焦慮藥物，如依替唑侖。

FPNV定位矩陣

FPNV 定位矩陣對於評估 Etizolam 市場供應商定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對依替唑侖市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭力的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在依替唑侖市場的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 由於焦慮症和失眠的增加，需求增加
      • 逐步改革醫療保健政策以促進獲得藥品
    • 抑制因素
      • 與產品召回相關的擔憂
    • 機會
      • 增加治療應用研發 (R&D) 的投資
      • 與其他製藥公司和學術機構共同開發
    • 任務
      • 仿冒品氾濫
  • 市場區隔分析
    • 形式：粉狀依替唑侖在錠劑和液體溶液製劑中的用途
    • 用途：依替唑侖常用於短期治療焦慮和恐慌發作。
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章 依替唑侖市場：依形式

  • 粉末
  • 解決方案
  • 藥片

第7章 依替唑侖市場：依應用分類

  • 焦慮
  • 失眠
  • 恐慌症

第8章 美洲依替唑侖市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區依替唑侖市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲的依替唑侖市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Hikma Pharmaceuticals 推出Diazepam注射液 USP 擴大美國產品組合
  • 戰略分析和建議

第12章競爭組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-5D693B46C001

[189 Pages Report] The Etizolam Market size was estimated at USD 68.15 million in 2023 and expected to reach USD 71.33 million in 2024, at a CAGR 4.86% to reach USD 95.07 million by 2030.

Etizolam is a chemical compound that belongs to the class of drugs known as thienodiazepines, which are similar in structure and function to benzodiazepines. It is used primarily for its sedative and anxiolytic properties, meaning it helps to reduce anxiety and promote sleep. It works by enhancing the effect of a neurotransmitter in the brain called GABA, which plays a role in regulating nervous system activity and has a calming effect on the body. While Etizolam can be effective for treating anxiety and insomnia, it is also associated with potential risks and side effects, including dependency. The increasing number of individuals suffering from anxiety and sleep disorders boosts the demand for effective therapeutic agents such as Etizolam, which is known for its efficacy in treating such conditions. However, the strict regulations related to the approval of Etizolam are a significant challenge for manufacturers. Moreover, recent technological advancements have allowed for more effective and targeted research in the field of medicine. For the etizolam market, increased R&D investment can lead to developing safer, more effective formulations with reduced side effects. This can broaden the therapeutic applications of Etizolam, potentially positioning it as a preferred option in treatments where benzodiazepine-like effects are desired.

KEY MARKET STATISTICS
Base Year [2023] USD 68.15 million
Estimated Year [2024] USD 71.33 million
Forecast Year [2030] USD 95.07 million
CAGR (%) 4.86%

Regional Insights

In the Americas, Etizolam is not approved by the U.S. Food and Drug Administration (FDA). It is illegal in several states within the U.S. due to concerns over abuse and addiction. Meanwhile, Canada recognizes the potential misuse of etizolam, which influences strict regulations and a focus on monitoring imports and distribution. The market in the Americas is strongly influenced by regulatory policies, which, in turn, affect consumer behavior significantly. In territories where it is restricted, there's a noticeable pivot towards purchasing legal and similarly effective alternatives. The United States, being a hub for pharmaceutical innovation, has several ongoing studies on safer alternatives to etizolam, focusing on reducing dependency risks. Patents usually revolve around formulation enhancements and new therapeutic applications for related substances. The legal status of etizolam varies by country within the EU; however, its use is generally more controlled compared to Asia, with strict regulations regarding prescription and distribution. EU countries focus extensively on mental health, which paves the way for research into safer and more effective alternatives to etizolam. In addition, the Middle East has stringent narcotic drug laws which reduce the availability of such compounds. In contrast, Africa has varying regulatory controls, influenced largely by individual country policies, which affect availability and consumer behavior. Moreover, Asia, China, Japan, and India are pivotal in the market of etizolam, primarily due to their large population bases and varying regulatory landscapes. In Japan, etizolam is notably used in medical settings but is strictly controlled. Unlike Japan, China and India have less stringent controls over etizolam, making it relatively more accessible and leading to different patterns of use and purchase. Recent investments in India and China focus on expanding pharmaceutical manufacturing capabilities, including producing various anxiolytics like etizolam.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Etizolam Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increased demand due to the rising prevalence of anxiety disorders and insomnia
      • Progressive reforms in healthcare policies facilitating drug accessibility
    • Market Restraints
      • Concerns associated with the product recall
    • Market Opportunities
      • Increased investment in research and development (R&D) for therapeutic applications
      • Collaborative development with other pharmaceutical companies and academic institutions
    • Market Challenges
      • Prevalence of counterfeit products
  • Market Segmentation Analysis
    • Form: Utilization of powdered Etizolam in the formulation of tablets and liquid solutions
    • Applications: Extensive usage of Etizolam for short-term treatment of anxiety and panic attacks
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Etizolam Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Etizolam Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Hikma Pharmaceuticals Expands US Portfolio with Introduction of Diazepam Injection USP

Hikma Pharmaceuticals has announced the launch of Diazepam Injection USP, a generic drug version. This product is intended for the treatment of conditions such as anxiety, muscle spasms, and certain types of seizures, offering a critical medical solution in both hospital and outpatient settings. As part of its ongoing commitment to addressing medicine shortages and critical care needs, Hikma emphasizes that this addition aligns with its mission to provide accessible, high-quality treatments that cater to urgent and essential therapeutic demands. [Published On: 2023-05-02]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Etizolam Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Etizolam Market, highlighting leading vendors and their innovative profiles. These include Arinna Lifescience Pvt Ltd., Centurion Laboratories, Chempro Pharma Private Limited, Consern Pharma Private Limited, Dr Reddy's Laboratories Ltd., Eridanus Healthcare, Inc., Hikma Pharmaceuticals PLC, Icon Life Sciences, Intas Pharmaceuticals Ltd., Jabs Biotech Pvt. Ltd., Macleods Pharmaceuticals Pvt Ltd., Mankind Pharma Ltd., Merck KGaA, Micro Labs Ltd., Neuracle Lifesciences Private Limited, NIHON GENERIC Co., Ltd., Santa Cruz Biotechnology, Inc., Sun Pharmaceutical Industries Ltd., Talent India, Tas Med India Pvt Ltd., and TCI Chemicals.

Market Segmentation & Coverage

This research report categorizes the Etizolam Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Form
    • Powders
    • Solutions
    • Tablet
  • Applications
    • Anxiety
    • Insomnia
    • Panic Disorders
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased demand due to the rising prevalence of anxiety disorders and insomnia
      • 5.1.1.2. Progressive reforms in healthcare policies facilitating drug accessibility
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with the product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased investment in research and development (R&D) for therapeutic applications
      • 5.1.3.2. Collaborative development with other pharmaceutical companies and academic institutions
    • 5.1.4. Challenges
      • 5.1.4.1. Prevalence of counterfeit products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Form: Utilization of powdered Etizolam in the formulation of tablets and liquid solutions
    • 5.2.2. Applications: Extensive usage of Etizolam for short-term treatment of anxiety and panic attacks
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Etizolam Market, by Form

  • 6.1. Introduction
  • 6.2. Powders
  • 6.3. Solutions
  • 6.4. Tablet

7. Etizolam Market, by Applications

  • 7.1. Introduction
  • 7.2. Anxiety
  • 7.3. Insomnia
  • 7.4. Panic Disorders

8. Americas Etizolam Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Etizolam Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Etizolam Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Hikma Pharmaceuticals Expands US Portfolio with Introduction of Diazepam Injection USP
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. ETIZOLAM MARKET RESEARCH PROCESS
  • FIGURE 2. ETIZOLAM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ETIZOLAM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ETIZOLAM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ETIZOLAM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ETIZOLAM MARKET DYNAMICS
  • FIGURE 7. GLOBAL ETIZOLAM MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ETIZOLAM MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ETIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ETIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ETIZOLAM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ETIZOLAM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ETIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ETIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ETIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ETIZOLAM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ETIZOLAM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. ETIZOLAM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ETIZOLAM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ETIZOLAM MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ETIZOLAM MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ETIZOLAM MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ETIZOLAM MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ETIZOLAM MARKET SIZE, BY POWDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ETIZOLAM MARKET SIZE, BY POWDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ETIZOLAM MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ETIZOLAM MARKET SIZE, BY SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ETIZOLAM MARKET SIZE, BY TABLET, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ETIZOLAM MARKET SIZE, BY TABLET, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ETIZOLAM MARKET SIZE, BY ANXIETY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ETIZOLAM MARKET SIZE, BY ANXIETY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL ETIZOLAM MARKET SIZE, BY INSOMNIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL ETIZOLAM MARKET SIZE, BY INSOMNIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL ETIZOLAM MARKET SIZE, BY PANIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL ETIZOLAM MARKET SIZE, BY PANIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. AMERICAS ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 24. AMERICAS ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 25. AMERICAS ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 26. AMERICAS ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS ETIZOLAM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS ETIZOLAM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 30. ARGENTINA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 32. ARGENTINA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 33. BRAZIL ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 34. BRAZIL ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 35. BRAZIL ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 36. BRAZIL ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 37. CANADA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 38. CANADA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 39. CANADA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 40. CANADA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 41. MEXICO ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 42. MEXICO ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 43. MEXICO ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 44. MEXICO ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 46. UNITED STATES ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 48. UNITED STATES ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ETIZOLAM MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 50. UNITED STATES ETIZOLAM MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ETIZOLAM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC ETIZOLAM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 58. AUSTRALIA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 60. AUSTRALIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 61. CHINA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 62. CHINA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 63. CHINA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 64. CHINA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 65. INDIA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 66. INDIA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 67. INDIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 68. INDIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 69. INDONESIA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 70. INDONESIA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 71. INDONESIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 72. INDONESIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 73. JAPAN ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 74. JAPAN ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 75. JAPAN ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 76. JAPAN ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 78. MALAYSIA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 79. MALAYSIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 80. MALAYSIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 82. PHILIPPINES ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 84. PHILIPPINES ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 86. SINGAPORE ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 87. SINGAPORE ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 88. SINGAPORE ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 90. SOUTH KOREA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 92. SOUTH KOREA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 93. TAIWAN ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 94. TAIWAN ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 95. TAIWAN ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 96. TAIWAN ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 97. THAILAND ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 98. THAILAND ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 99. THAILAND ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 100. THAILAND ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 101. VIETNAM ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 102. VIETNAM ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 103. VIETNAM ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 104. VIETNAM ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA ETIZOLAM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA ETIZOLAM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 111. DENMARK ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 112. DENMARK ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 113. DENMARK ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 114. DENMARK ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 115. EGYPT ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 116. EGYPT ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 117. EGYPT ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 118. EGYPT ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 119. FINLAND ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 120. FINLAND ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 121. FINLAND ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 122. FINLAND ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 123. FRANCE ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 124. FRANCE ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 125. FRANCE ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 126. FRANCE ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 127. GERMANY ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 128. GERMANY ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 129. GERMANY ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 130. GERMANY ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 131. ISRAEL ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 132. ISRAEL ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 133. ISRAEL ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 134. ISRAEL ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 135. ITALY ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 136. ITALY ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 137. ITALY ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 138. ITALY ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 140. NETHERLANDS ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 142. NETHERLANDS ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 143. NIGERIA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 144. NIGERIA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 145. NIGERIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 146. NIGERIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 147. NORWAY ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 148. NORWAY ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 149. NORWAY ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 150. NORWAY ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 151. POLAND ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 152. POLAND ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 153. POLAND ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 154. POLAND ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 155. QATAR ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 156. QATAR ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 157. QATAR ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 158. QATAR ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 159. RUSSIA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 160. RUSSIA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 161. RUSSIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 162. RUSSIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 164. SAUDI ARABIA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 166. SAUDI ARABIA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH AFRICA ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH AFRICA ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 171. SPAIN ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 172. SPAIN ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 173. SPAIN ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 174. SPAIN ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 175. SWEDEN ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 176. SWEDEN ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 177. SWEDEN ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 178. SWEDEN ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 180. SWITZERLAND ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 182. SWITZERLAND ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 183. TURKEY ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 184. TURKEY ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 185. TURKEY ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 186. TURKEY ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ETIZOLAM MARKET SIZE, BY FORM, 2018-2023 (USD MILLION)
  • TABLE 192. UNITED KINGDOM ETIZOLAM MARKET SIZE, BY FORM, 2024-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 194. UNITED KINGDOM ETIZOLAM MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 195. ETIZOLAM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. ETIZOLAM MARKET, FPNV POSITIONING MATRIX, 2023